<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84971635810</prism:url><dc:identifier>SCOPUS_ID:84971635810</dc:identifier><eid>2-s2.0-84971635810</eid><prism:doi>10.1177/1535370216640944</prism:doi><dc:title>Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>1</citedby-count><prism:publicationName>Experimental Biology and Medicine</prism:publicationName><dc:publisher> SAGE Publications Inc. claims@sagepub.com </dc:publisher><source-id>50101</source-id><prism:issn>15353699</prism:issn><prism:volume>241</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:startingPage>1007</prism:startingPage><prism:endingPage>1013</prism:endingPage><prism:pageRange>1007-1013</prism:pageRange><prism:coverDate>2016-01-01</prism:coverDate><dc:creator><author auid="56423300100" seq="1"><ce:initials>C.M.</ce:initials><ce:indexed-name>Knapp C.M.</ce:indexed-name><ce:surname>Knapp</ce:surname><ce:given-name>Christopher M</ce:given-name><preferred-name> <ce:initials>C.M.</ce:initials> <ce:indexed-name>Knapp C.</ce:indexed-name> <ce:surname>Knapp</ce:surname> <ce:given-name>Christopher M.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56423300100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"> <publishercopyright>© 2016, © 2016 by the Society for Experimental Biology and Medicine.</publishercopyright> <ce:para>Conventional chemo-immunotherapy fails to cure the majority of mantle cell lymphoma patients and causes substantial toxicity. Resistant mantle cell lymphoma cells commonly overexpress and are dependent on the anti-apoptotic protein, Mcl-1, for survival. In this study, we use potent lipidoid nanoparticles to deliver siRNA to silence Mcl-1 expression. Studies were conducted using two different mantle cell lymphoma cell lines, a normal (JeKo-1) and an aggressive (MAVER-1) line, to assess the ability of lipidoid nanoparticles to be used broadly in the treatment of mantle cell lymphoma. Mcl-1 mRNA silencing and protein knockdown was observed as early as one day after treatment and the lipidoid nanoparticles achieved sustained silencing of Mcl-1 mRNA for at least four days in both JeKo-1 and MAVER-1 cells. Eighty percent silencing was achieved at three days post-transfection in JeKo-1 cells while 50% silencing was achieved in MAVER-1 cells, which are more resistant to transfection. Interestingly, silencing of Mcl-1 induced apoptosis in nearly 30% of both JeKo-1 and MAVER-1 cells three days post-transfection. Additionally, Mcl-1 silencing and the resultant apoptosis in mantle cell lymphoma cells were dose dependent. These data suggest that lipidoid nanoparticles siRNA therapy targeting Mcl-1 has potential as a new treatment modality for mantle cell lymphoma and many other cancers that overexpress Mcl-1. The combination of anti-Mcl-1 lipidoid nanoparticles with other forms of targeted therapy offers hope for reducing or replacing cytotoxic chemotherapy as standard treatment for mantle cell lymphoma.</ce:para> </abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84971635810" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=84971635810&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=84971635810&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/106683239" id="106683239"><affilname>Allegheny Health Network</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author auid="56423300100" seq="1"><ce:initials>C.M.</ce:initials><ce:indexed-name>Knapp C.M.</ce:indexed-name><ce:surname>Knapp</ce:surname><ce:given-name>Christopher M</ce:given-name><preferred-name> <ce:initials>C.M.</ce:initials> <ce:indexed-name>Knapp C.</ce:indexed-name> <ce:surname>Knapp</ce:surname> <ce:given-name>Christopher M.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/56423300100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author><author auid="57189516478" seq="2"><ce:initials>J.</ce:initials><ce:indexed-name>He J.</ce:indexed-name><ce:surname>He</ce:surname><ce:given-name>Jia</ce:given-name><preferred-name> <ce:initials>J.</ce:initials> <ce:indexed-name>He J.</ce:indexed-name> <ce:surname>He</ce:surname> <ce:given-name>Jia</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/57189516478</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author><author auid="7201547379" seq="3"><ce:initials>J.</ce:initials><ce:indexed-name>Lister J.</ce:indexed-name><ce:surname>Lister</ce:surname><ce:given-name>John</ce:given-name><preferred-name> <ce:initials>J.</ce:initials> <ce:indexed-name>Lister J.</ce:indexed-name> <ce:surname>Lister</ce:surname> <ce:given-name>John</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7201547379</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/106683239" id="106683239"/></author><author auid="35609935600" seq="4"><ce:initials>K.A.</ce:initials><ce:indexed-name>Whitehead K.A.</ce:indexed-name><ce:surname>Whitehead</ce:surname><ce:given-name>Kathryn A</ce:given-name><preferred-name> <ce:initials>K.A.</ce:initials> <ce:indexed-name>Whitehead K.</ce:indexed-name> <ce:surname>Whitehead</ce:surname> <ce:given-name>Kathryn A.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/35609935600</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></authors></abstracts-retrieval-response>
